PT  - JOURNAL ARTICLE
AU  - Teng, Eva
AU  - Pignanelli, Marcelle
AU  - Hammad, Faiza
AU  - Wisa, David
TI  - A COVID-19 patient with recurrent acute limb ischaemia despite two successive types of therapeutic dose anticoagulation and thrombolysis
AID  - 10.1136/bcr-2021-245040
DP  - 2021 Aug 01
TA  - BMJ Case Reports
PG  - e245040
VI  - 14
IP  - 8
4099  - http://casereports.bmj.com/content/14/8/e245040.short
4100  - http://casereports.bmj.com/content/14/8/e245040.full
SO  - BMJ Case Reports2021 Aug 01; 14
AB  - COVID-19 is caused by the SARS-CoV-2, and its presentation ranges from mild upper respiratory illness to critical disease including acute respiratory distress syndrome and multiorgan dysfunction. While it was initially believed to primarily target the respiratory system, numerous studies have demonstrated it to cause a hypercoagulable state that predisposes to arterial and venous thrombosis. We present a case where a patient with COVID-19 developed acute lower limb ischaemia due to arterial thrombosis in the setting of full-dose enoxaparin, followed by heparin infusion protocol. The patient developed recurrent ischaemia despite thrombolysis in addition to anticoagulation, and eventually required open thrombectomy before making a full recovery.